FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947487250> ?p ?o ?g. }

• W2947487250 abstract "Background Type 1 diabetes mellitus (T1D) is an organ-specific autoimmune disease characterized by the presence of circulating, islet-specific, pancreatic auto-antibodies against glutamic acid decarboxylase (GAD65) and the destruction of insulin-producing pancreatic beta cells. An increased risk of developing other serological manifestations and autoimmune diseases has been described, mainly of the thyroid (20% with antithyroid antibodies) and celiac disease (5%). In addition, it has also been described in association with Addison’s disease, autoimmune polyglandular syndrome, psoriasis and other systemic autoimmune comorbidities diseases such as rheumatoid arthritis (RA), systemic juvenile idiopathic arthritis and Sjogren’s syndrome. It also has been suggested that T1D might has a genetic factor, pathogenic pathways with pleiotropic effects, and cytokines such as interferon type I, among others. Objectives 1) Study the prevalence of autoimmune comorbidities in patients with T1D. 2) Describe the clinical-immunologic profiles of these patients. Methods A descriptive, retrospective study of a cohort of patients diagnosed with T1D, according to ADA (American Diabetes Association), follow-up by Endocrinology and Rheumatology Units of a 3rd level hospital from June 1975 to July 2018. Clinical and analytical-immunologic variables were collected. Statistical analysis was was performed with SPSS.25. Results We included 116 patients from which 55% were women, with a mean age at diagnosis of T1D 18.7 (± 12.3 SD) years. Average age at autoimmune disease diagnosis was 38.8 (± 12.2 SD) years. Average time of evolution between onset of T1D and autoimmune comorbidity was 10.1 (± 10.6 SD) years, except one patient with autoimmune thyroiditis 10 years before T1D. Autoimmune manifestations were showed by 19/116 patients (16.4%), with the following diagnoses: autoimmune hypothyroidism: 10 patients (8.6%); autoimmune polyglandular syndrome: 3 patients (2.6%), RA in 2 patients (1.8%). As well, 1 patient with celiac disease, 1 with cutaneous lupus erythematosus (CLE), 1 with psoriasis and another one with IgG4-related orbital inflammatory disease, (0.9% respectively). Three patients developed articular manifestations (2 rheumatoid polyarthritis and 1 with limited joint mobility or cheiroarthropathy). 4/19 patients (21%) showed cutaneous lesions (2 with vitiligo, 1 CLE and 1 with psoriasis.. Hematological alterations type pernicious anemia in one patient. No visceral involvement was found. Antibodies were detected to be organ-specific: 7/17 antibodies to thyroid peroxidase (TPO) (+) and 3/17 antibodies to thyroglobulin (+) and one with anti-gliadin IgA (+). ANA (+) was detected in four patients (two fine granular pattern, one nucleolar and one homogeneous) with negative specificities and 1 patient RF (+). No Anti-CCP antibodies were detected. Conclusion 1) 16% of patients with T1D presented autoimmune comorbidity at 10 years after the onset of endocrinopathy. 2) Autoimmune hypothyroidism was the most prevalent autoimmune manifestation (8.6%), followed by autoimmune polyglandular syndrome and RA, similar to other studies. 3) We highlight the unusual finding of IgG4-related orbital inflammation as comorbidity of T1D. 4) The cutaneous lesions (21%) were the most common clinical manifestation in patients with T1D and autoimmunity. We emphasize the absence of visceral involvement. References [1] -Lynne et col, 2018, Associated autoimmune diseases in children and adolescents with T1D, uptodate. [2] -Jiang P et col, 2015, Diabetes Mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. [3] -Kiani AK et col, 2015, Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients. [4] -Zheng WY et col, 2016Detecting shared pathways linked to rheumatoid arthritis with other autoimmune disease in a in silica analysis. Disclosure of Interests None declared" @default.
• W2947487250 created "2019-06-07" @default.
• W2947487250 creator A5051147186 @default.
• W2947487250 date "2019-06-01" @default.
• W2947487250 modified "2023-09-23" @default.
• W2947487250 title "FRI0606 AUTOIMMUNE MANIFESTATIONS IN A COHORT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS" @default.
• W2947487250 doi "https://doi.org/10.1136/annrheumdis-2019-eular.7982" @default.
• W2947487250 hasPublicationYear "2019" @default.
• W2947487250 type Work @default.
• W2947487250 sameAs 2947487250 @default.
• W2947487250 citedByCount "0" @default.
• W2947487250 crossrefType "proceedings-article" @default.
• W2947487250 hasAuthorship W2947487250A5051147186 @default.
• W2947487250 hasBestOaLocation W29474872501 @default.
• W2947487250 hasConcept C126322002 @default.
• W2947487250 hasConcept C134018914 @default.
• W2947487250 hasConcept C159654299 @default.
• W2947487250 hasConcept C163764329 @default.
• W2947487250 hasConcept C198451711 @default.
• W2947487250 hasConcept C203014093 @default.
• W2947487250 hasConcept C2776362883 @default.
• W2947487250 hasConcept C2777077863 @default.
• W2947487250 hasConcept C2777575956 @default.
• W2947487250 hasConcept C2778696486 @default.
• W2947487250 hasConcept C2779075594 @default.
• W2947487250 hasConcept C2779134260 @default.
• W2947487250 hasConcept C2779159551 @default.
• W2947487250 hasConcept C2781232474 @default.
• W2947487250 hasConcept C555293320 @default.
• W2947487250 hasConcept C71924100 @default.
• W2947487250 hasConcept C72563966 @default.
• W2947487250 hasConceptScore W2947487250C126322002 @default.
• W2947487250 hasConceptScore W2947487250C134018914 @default.
• W2947487250 hasConceptScore W2947487250C159654299 @default.
• W2947487250 hasConceptScore W2947487250C163764329 @default.
• W2947487250 hasConceptScore W2947487250C198451711 @default.
• W2947487250 hasConceptScore W2947487250C203014093 @default.
• W2947487250 hasConceptScore W2947487250C2776362883 @default.
• W2947487250 hasConceptScore W2947487250C2777077863 @default.
• W2947487250 hasConceptScore W2947487250C2777575956 @default.
• W2947487250 hasConceptScore W2947487250C2778696486 @default.
• W2947487250 hasConceptScore W2947487250C2779075594 @default.
• W2947487250 hasConceptScore W2947487250C2779134260 @default.
• W2947487250 hasConceptScore W2947487250C2779159551 @default.
• W2947487250 hasConceptScore W2947487250C2781232474 @default.
• W2947487250 hasConceptScore W2947487250C555293320 @default.
• W2947487250 hasConceptScore W2947487250C71924100 @default.
• W2947487250 hasConceptScore W2947487250C72563966 @default.
• W2947487250 hasLocation W29474872501 @default.
• W2947487250 hasOpenAccess W2947487250 @default.
• W2947487250 hasPrimaryLocation W29474872501 @default.
• W2947487250 hasRelatedWork W1688294308 @default.
• W2947487250 hasRelatedWork W1964115141 @default.
• W2947487250 hasRelatedWork W2025829732 @default.
• W2947487250 hasRelatedWork W2031294079 @default.
• W2947487250 hasRelatedWork W2035899028 @default.
• W2947487250 hasRelatedWork W2140858255 @default.
• W2947487250 hasRelatedWork W2150700895 @default.
• W2947487250 hasRelatedWork W2229425902 @default.
• W2947487250 hasRelatedWork W2259990716 @default.
• W2947487250 hasRelatedWork W2314257258 @default.
• W2947487250 hasRelatedWork W2402530035 @default.
• W2947487250 hasRelatedWork W2416318173 @default.
• W2947487250 hasRelatedWork W2603834227 @default.
• W2947487250 hasRelatedWork W2947456971 @default.
• W2947487250 hasRelatedWork W3045279039 @default.
• W2947487250 hasRelatedWork W3090496908 @default.
• W2947487250 hasRelatedWork W3120430489 @default.
• W2947487250 hasRelatedWork W3131918768 @default.
• W2947487250 hasRelatedWork W3136858905 @default.
• W2947487250 hasRelatedWork W3138883876 @default.
• W2947487250 isParatext "false" @default.
• W2947487250 isRetracted "false" @default.
• W2947487250 magId "2947487250" @default.
• W2947487250 workType "article" @default.